Respiratory concerns of gabapentin and pregabalin: What does it mean to the pharmacovigilance systems in developing countries? [version 2; peer review: 2 approved]
Gabapentin and pregabalin, commonly known as gabapentinoids, have been widely used globally. This paper highlights the serious breathing problems due to using gabapentin and pregabalin which was warned by the United States Food and Drug Administration on December, 2019. In this article, we tried to...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2021-02-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/9-32/v2 |